JP2020507623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020507623A5 JP2020507623A5 JP2019563680A JP2019563680A JP2020507623A5 JP 2020507623 A5 JP2020507623 A5 JP 2020507623A5 JP 2019563680 A JP2019563680 A JP 2019563680A JP 2019563680 A JP2019563680 A JP 2019563680A JP 2020507623 A5 JP2020507623 A5 JP 2020507623A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutical composition
- peptide
- human
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024019238A JP2024056838A (ja) | 2017-02-06 | 2024-02-13 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
| JP2026061398A JP2026117044A (ja) | 2017-02-06 | 2026-04-02 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17154889 | 2017-02-06 | ||
| EP17154889.4 | 2017-02-06 | ||
| PCT/EP2018/052822 WO2018141969A1 (en) | 2017-02-06 | 2018-02-05 | Peptide modulators of the interaction between human c-peptide and human elastin receptor for therapeutic use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024019238A Division JP2024056838A (ja) | 2017-02-06 | 2024-02-13 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020507623A JP2020507623A (ja) | 2020-03-12 |
| JP2020507623A5 true JP2020507623A5 (enExample) | 2021-03-04 |
| JP7438757B2 JP7438757B2 (ja) | 2024-02-27 |
Family
ID=57995050
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563680A Active JP7438757B2 (ja) | 2017-02-06 | 2018-02-05 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
| JP2024019238A Pending JP2024056838A (ja) | 2017-02-06 | 2024-02-13 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
| JP2026061398A Pending JP2026117044A (ja) | 2017-02-06 | 2026-04-02 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024019238A Pending JP2024056838A (ja) | 2017-02-06 | 2024-02-13 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
| JP2026061398A Pending JP2026117044A (ja) | 2017-02-06 | 2026-04-02 | 治療用途のためのヒトｃペプチドとヒトエラスチン受容体との相互作用のペプチドモジュレーター |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20200087374A1 (enExample) |
| EP (3) | EP3577462B1 (enExample) |
| JP (3) | JP7438757B2 (enExample) |
| AU (2) | AU2018216033B2 (enExample) |
| CA (2) | CA3051293A1 (enExample) |
| ES (1) | ES2927977T3 (enExample) |
| SG (2) | SG11201906939XA (enExample) |
| WO (2) | WO2018141969A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6982395B2 (ja) * | 2017-03-16 | 2021-12-17 | 三洋化成工業株式会社 | インターロイキン１０の産生量増加剤 |
| WO2019104391A1 (en) * | 2017-12-01 | 2019-06-06 | St Vincent's Institute Of Medical Research | Type 1 diabetes treatment |
| EP4021481A1 (en) * | 2019-08-30 | 2022-07-06 | Biotempt B.V. | Q-er peptide |
| JP6895148B1 (ja) * | 2020-03-31 | 2021-06-30 | クラシエホールディングス株式会社 | 冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定用マーカー、冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定する判定方法、及び冷え保有者における冷えの原因が、腎機能低下、水分代謝異常又は副腎疲労にあることを判定するための判定用キット |
| CN117106029A (zh) * | 2020-06-08 | 2023-11-24 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
| JP2023544832A (ja) * | 2020-10-08 | 2023-10-25 | ドクター メアリー モリス アンド アソシエイツ リミテッド ライアビリティ カンパニー | １型糖尿病の治療および予防のための方法および組成物 |
| CN112345770A (zh) * | 2020-11-06 | 2021-02-09 | 苏州大学附属第一医院 | 弹性蛋白降解肽作为腹膜透析患者血管钙化标志物的应用 |
| KR102718109B1 (ko) * | 2021-10-01 | 2024-10-17 | (주)케어젠 | 탈모 방지 또는 발모 촉진 활성을 갖는 펩타이드와 이의 용도 |
| CA3234504A1 (en) * | 2021-10-05 | 2023-04-13 | Biotempt B.V. | Angiogenic control, preferably combined with glycaemic control. |
| JP2025525516A (ja) | 2022-07-12 | 2025-08-05 | リシリアン ベー．フェー． | 高インスリン血症と関連する低血糖症を伴う状態の処置 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
| US6734289B2 (en) | 2001-03-29 | 2004-05-11 | The University Of Chicago | Gastrokines and derived peptides including inhibitors |
| AU2003228382A1 (en) * | 2002-03-27 | 2003-10-13 | University Of Utah Research Foundation | Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| GB0218970D0 (en) | 2002-08-14 | 2002-09-25 | Creative Peptides Sweden Ab | Fragments of Insulin c-peptide |
| GB0323979D0 (en) | 2003-10-13 | 2003-11-19 | Creative Peptides Sweden Ab | Therapeutic applications for c-peptide |
| GB0412174D0 (en) | 2004-06-01 | 2004-06-30 | Creative Peptides Sweden Ab | Degradation-resistant analogues of pro-insulin c-peptide |
| WO2008118387A2 (en) * | 2007-03-23 | 2008-10-02 | Wayne State University | Erythrocyte atp-release modulators |
| AU2010298036B2 (en) * | 2009-09-25 | 2015-05-21 | Xoma Technology Ltd. | Screening methods |
| KR20140128314A (ko) * | 2012-02-01 | 2014-11-05 | 에프. 호프만-라 로슈 아게 | 다중특이적 결합제의 결합 파트너 검출 방법 |
| DK2626704T3 (en) * | 2012-02-08 | 2016-02-22 | Mehmet Ali Soylemez | Diagnosis of pancreatic diabetes in patients with normal blood leucocyte counts using procalcitonin |
| IN2014MN02101A (enExample) * | 2012-04-12 | 2015-08-28 | Brahms Gmbh | |
| WO2014028776A1 (en) * | 2012-08-15 | 2014-02-20 | Zyngenia, Inc. | Monovalent and multivalent multispecific complexes and uses thereof |
| RU2677895C2 (ru) * | 2013-01-08 | 2019-01-22 | Сфинготек Гмбх | Уровни гормона роста натощак в качестве прогностического маркера сердечно-сосудистого риска |
| WO2014145836A1 (en) * | 2013-03-15 | 2014-09-18 | Health Diagnostic Laboratory, Inc. | Method of generating an index score for mbl deficiency to predict cardiodiabetes risk |
| CN104371003B (zh) | 2013-08-15 | 2025-09-02 | 上海市第一人民医院 | 预防和治疗炎症的小分子多肽及其应用 |
| CN110161252B (zh) * | 2014-03-21 | 2022-10-14 | 赛诺菲-安万特德国有限公司 | 用于评估心血管病症进展风险的新标志物 |
-
2018
- 2018-02-05 ES ES18705843T patent/ES2927977T3/es active Active
- 2018-02-05 SG SG11201906939XA patent/SG11201906939XA/en unknown
- 2018-02-05 AU AU2018216033A patent/AU2018216033B2/en active Active
- 2018-02-05 US US16/483,717 patent/US20200087374A1/en not_active Abandoned
- 2018-02-05 AU AU2018215245A patent/AU2018215245B2/en not_active Ceased
- 2018-02-05 EP EP18705844.1A patent/EP3577462B1/en active Active
- 2018-02-05 CA CA3051293A patent/CA3051293A1/en active Pending
- 2018-02-05 EP EP18705843.3A patent/EP3570875B1/en active Active
- 2018-02-05 JP JP2019563680A patent/JP7438757B2/ja active Active
- 2018-02-05 EP EP24170487.3A patent/EP4421088A3/en not_active Withdrawn
- 2018-02-05 SG SG11201906943VA patent/SG11201906943VA/en unknown
- 2018-02-05 CA CA3049738A patent/CA3049738A1/en active Pending
- 2018-02-05 US US16/483,317 patent/US20220009988A1/en not_active Abandoned
- 2018-02-05 WO PCT/EP2018/052822 patent/WO2018141969A1/en not_active Ceased
- 2018-02-05 WO PCT/EP2018/052824 patent/WO2018141970A1/en not_active Ceased
-
2023
- 2023-05-01 US US18/310,188 patent/US20240027431A1/en not_active Abandoned
-
2024
- 2024-02-13 JP JP2024019238A patent/JP2024056838A/ja active Pending
- 2024-11-26 US US18/960,532 patent/US20250123275A1/en active Pending
-
2026
- 2026-04-02 JP JP2026061398A patent/JP2026117044A/ja active Pending